Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Mexico Medical Devices Market reached a value of USD 8.41 Billion at 2025 and is projected to expand at a CAGR of around 5.30% during the forecast period of 2026-2035. With nearshoring-led manufacturing expansion, COFEPRIS regulatory streamlining, IMSS-Bienestar hospital build-out, and rising chronic disease burden, the market is expected to reach USD 14.10 Billion.

Key Market Trends and Insights

  • Northern Mexico (the Baja California–Sonora–Chihuahua manufacturing belt) is expected to record a CAGR of 6.0% over the forecast period, led by Tijuana, Ciudad Juárez and Mexicali clusters that already account for nearly half of national medical device employment.
  • The diagnostic imaging devices category is expected to exhibit a CAGR of 6.1% over the forecast period, supported by IMSS hospital openings equipped with CT, MRI and ultrasound suites and growing private medical-tourism investment in advanced imaging.
  • Cardiology applications are anticipated to register a CAGR of 5.8% during the forecast period, driven by the high mortality burden of ischemic heart disease and growing adoption of stents, catheters and electrophysiology devices in Mexican tertiary hospitals.

Market Size and Forecast

  • Market Size (2025): USD 8.41 Billion
  • Projected Market Size (2035): USD 14.10 Billion
  • Compound Annual Growth Rate (CAGR) (2026-2035): 5.30%
2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

  • According to Dongning Su et al., 2025, Mexico is projected to witness a 171% rise in patient numbers from 2021 to 2050, significantly driving demand for advanced medical devices and boosting market growth.

  • After December 2024, increasing nearshoring of manufacturing in Mexico, supported by supply chain resilience and cost efficiency, is accelerating growth in the medical devices market, making the country a key production hub despite tariff pressures.

  • One of the major market drivers is the launch of Mexico’s new consolidated procurement model. For instance, in October 2024, the government announced a 130-billion-peso investment to streamline procurement and boost medical device accessibility.

Compound Annual Growth Rate

5.3%

Value in USD Billion

2026-2035


*this image is indicative*

Key Trends and Recent Developments

Mexico Medical Devices Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

  • Respiratory Devices
  • Cardiology Devices
    • Diagnostic & Monitoring Devices
      • Electrocardiogram (ECG)
      • Remote Cardiac Monitoring Devices
      • Others
    • Therapeutic & Surgical Devices
      • Stents
      • Catheters
      • Grafts
      • Heart Valves
  • Orthopedic Devices
    • Replacement Devices
    • Bone Fixation Devices
    • Orthobiologics
    • Braces
    • Others
  • Diagnostic Imaging Devices
    • X-Ray Machines
    • MRI Scanners
    • CT Scanners
    • Ultrasound Systems
    • Nuclear Imaging Devices
    • Others
  • Endoscopy Devices
    • Rigid Endoscopy Devices
    • Flexible Endoscopy Devices
    • Capsule Endoscopy Devices
    • Disposable Endoscopy Devices
    • Robot Assisted Endoscopy Devices
    • Endoscopy Visualization Component
    • Operative Devices
    • Others
  • Ophthalmology Devices
    • Optical Coherence Tomography Scanners
    • Fundus Cameras
    • Perimeters/Visual Field Analyzers
    • Autorefractors and Keratometers
    • Slit Lamps
    • Wavefront Aberrometers
    • Optical Biometry Systems
    • Corneal Topography Systems
    • Specular Microscopes
    • Retinoscopes
    • Others
  • Others

Key Insight: Diagnostic imaging devices anchor the product mix in Mexico, supported by a steady wave of CT, MRI, ultrasound and digital X-ray procurement under IMSS-Bienestar and ISSSTE modernisation, plus premium installations by border medical-tourism hospitals. The Mexico diagnostic imaging equipment market alone was valued at about USD 1.13 billion in 2025 and is projected to reach USD 1.61 billion by 2031 at a 6.05% CAGR, with MRI revenues rising fastest at around 8% CAGR. Cardiology devices are a close second, driven by stent, catheter, ECG and electrophysiology demand. Vendors such as GE HealthCare, Siemens Healthineers, Philips, Medtronic and Abbott are layering AI-enabled imaging and connected-device platforms on top of the installed base, lifting average selling prices.

Market Breakup by Application

  • Cardiology
  • Neurology
  • Orthopedics
  • Diabetes Care
  • Respiratory
  • Ophthalmology
  • Oncology
  • Others

Key Insight: Cardiology is the leading application in Mexico and is expected to retain that position through the forecast period, accounting for roughly 28% of medical device revenue. The driver is structural: ischemic heart disease together with diabetes mellitus produced more than 200,000 deaths in 2022, making cardiovascular conditions the single largest mortality cluster in the country. This translates into sustained demand for stents, catheters, pacemakers, defibrillators, ECG and remote cardiac monitoring solutions across IMSS, ISSSTE and private hospital networks. Diabetes care, oncology and orthopedics follow as material categories, all benefiting from rising procedural volumes, an ageing population and growing acceptance of minimally invasive techniques.

Market Breakup by End User

Key Insight: Hospitals are the dominant end user, absorbing the majority of high-value diagnostic, surgical and cardiology equipment sold in Mexico. Public networks (IMSS, ISSSTE and IMSS-Bienestar) are scaling capacity, with 31 hospitals and 12 clinics targeted for inauguration by end-2025 and around 256 operating rooms being upgraded across the three systems. Specialty clinics are growing fastest, particularly in dental, ophthalmology, dermatology and fertility, often clustered in border cities serving medical-tourism inflows. Homecare adoption is climbing on the back of remote patient monitoring, wearables and connected respiratory and diabetes devices, while ambulatory surgical centres are extending procedure mix into orthopedics and minimally invasive cardiology.

Market Breakdown by Region

  • Northern Mexico
  • Central Mexico
  • Southern Mexico

Key Insight: Northern Mexico is the leading regional cluster, anchored by Tijuana and Mexicali in Baja California, Ciudad Juárez in Chihuahua, and Hermosillo in Sonora. Baja California alone hosts roughly 44 medical device companies, around 42,000 jobs and approximately USD 3 billion in annual exports, while Chihuahua employs about 40,000 people in the sector. The state of Querétaro, in central Mexico, is being elevated by Abbott’s USD 200 million electrophysiology plant inaugurated in early 2026, which is expected to scale toward 1,200 specialised positions by the end of the decade. Guadalajara has emerged as the R&D and electronics-focused medtech hub. Demand drivers include nearshoring under USMCA, federal Plan México incentives, IMSS-Bienestar hospital openings, and an installed base of more than 700 specialised companies and 160,000 sector workers.

Mexico Medical Devices Market Share

By Product: Imaging Devices Lead on Public Healthcare Investments

Diagnostic imaging devices represent the leading product category in Mexico, capturing the largest single share of medical device spending. The pull comes from public-sector modernisation: nine new IMSS hospitals slated for 2025 are being equipped with CT, MRI, ultrasound and digital X-ray suites, and Chiapas alone received around MX$677.5 million (USD 35 million) for imaging upgrades. The forthcoming 260-bed IMSS hospital in Nuevo León (budgeted at about USD 165 million) will feature hybrid operating rooms with interventional imaging. Private medical-tourism hospitals along the border install premium MRI and CT scanners to serve U.S. patients, reinforcing the segment’s dominance. Cardiology devices follow closely, with the cardiology application expected to lead with around a 28% share of total device revenue.

By Application: Cardiology Dominates Amid Rising Disease Burden

Cardiology is the dominant application segment, projected to capture approximately 28% of Mexico’s medical device revenue. The reason is the country’s disease profile: cardiac diseases - 76.3% of which are ischemic heart disease - together with diabetes mellitus accounted for more than 200,000 deaths in 2022 according to peer-reviewed Mexican mortality data. This drives sustained demand for diagnostic ECG, remote cardiac monitoring, stents, catheters, heart valves and electrophysiology devices, supplied by Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, GE HealthCare, Siemens Healthineers and Philips. Abbott’s January 2026 inauguration of a USD 200 million electrophysiology plant in Querétaro is the most visible signal of cardiology’s share leadership and the reason it continues to attract dedicated FDI.

By End User: Hospitals Anchor Demand Through Large-Scale Procurement

Hospitals dominate the end-user mix, mirroring the broader Latin American pattern in which hospitals and ambulatory surgical centres account for roughly 62% of regional device consumption. In Mexico, IMSS, ISSSTE and IMSS-Bienestar collectively control most public-sector procurement, and the 2025-2026 consolidated procurement programme - covering 4.9 billion units across more than 4,400 product codes - runs through hospital networks. The federal government is also upgrading 256 operating rooms across the three systems and has allocated about MX$1.7 billion (USD 100 million) for 123 imaging systems across 26 states. This institutional purchasing power, combined with private hospital expansion and medical-tourism investment, secures hospitals as the principal device demand centre, while specialty clinics expand fastest in absolute growth terms.

Regional Analysis

Northern Mexico

Northern Mexico is the country’s manufacturing engine for medical devices and the dominant regional sub-market on the supply side. The Baja California cluster, anchored by Tijuana and Mexicali, hosts about 44 medical device companies, 42,000 jobs and around USD 3 billion in annual exports. Becton Dickinson is investing roughly USD 80 million in a third Ciudad Juárez plant scheduled to begin operations in 2026, while Stryker, Medtronic, Johnson & Johnson MedTech and Becton Dickinson all operate multiple plants across Tijuana, Mexicali and Juárez. Demand drivers include USMCA duty-free access to the U.S. market, 24–48-hour border logistics, and labour costs at roughly one-fifth of U.S. levels. Border medical-tourism hospitals further boost local installed-base demand for imaging and orthopedic systems.

Central Mexico

Central Mexico - covering Mexico City, Querétaro, Guanajuato and Jalisco - is the country’s fastest-rising regional sub-market on the demand side and an emerging manufacturing pole. Querétaro has been transformed by Abbott’s USD 200 million electrophysiology plant, inaugurated in January 2026, which currently employs about 300 staff and is scaling to over 1,200 positions; the state has a pipeline of around 57 investment projects totalling close to USD 3.75 billion. Guadalajara, in Jalisco, hosts the high-tech medtech R&D ecosystem (often called the country’s “Silicon Valley”). Mexico City concentrates the largest hospital networks, multinational commercial offices and flagship public institutes such as the Instituto Nacional de Pediatría, where United Imaging deployed Mexico’s first digital pediatric PET/CT in July 2024.

Leading Players in the Mexico Medical Devices Market

The Mexico medical devices market is moderately consolidated. A small number of multinationals - Medtronic, Johnson & Johnson MedTech, Abbott, GE Healthcare, Siemens Healthineers, Koninklijke Philips, Fresenius Medical Care and 3M - dominate the high-value cardiology, imaging, dialysis and surgical segments, while a long tail of distributors and contract manufacturers supports them across Tijuana, Juárez, Querétaro and Guadalajara.

Competitive priorities have shifted from pure price to operational fit, regulatory speed under the COFEPRIS abbreviated pathway, and AI-enabled product platforms. Strategic moves are focused on near-shore capacity expansion (Abbott Querétaro, BD Juárez), cardiovascular and diabetes franchise reinforcement (Medtronic-Abbott CGM partnership, GE HealthCare Revolution Vibe CT) and selective M&A - including Abbott’s pending USD 21 billion acquisition of Exact Sciences and GE HealthCare’s USD 2.3 billion deal for Intelerad - that reshape the broader competitive set serving Mexico.

Medtronic plc

Founded in 1949 and headquartered in Dublin, Ireland (operational HQ in Minneapolis, USA), Medtronic plc is the world’s largest medical device company. It focuses on cardiovascular, neuromodulation, surgical and diabetes technologies. In Mexico, Medtronic operates around six manufacturing facilities, including a major plant in Tijuana, with more than 13,000 employees, making it the country’s largest medtech employer and a cornerstone of the cardiology and diabetes device supply chain.

Johnson & Johnson MedTech

Founded in 1886 and headquartered in New Brunswick, New Jersey (USA), Johnson & Johnson MedTech is the medical devices arm of Johnson & Johnson, with strengths in orthopedics (DePuy Synthes), surgical instruments (Ethicon), cardiovascular and vision care. In Mexico, the company operates manufacturing and commercial activities through Johnson & Johnson de México, S.A. de C.V., supplying hospitals nationwide with surgical, orthopedic and wound-care portfolios.

Abbott

Founded in 1888 and headquartered in Abbott Park, Illinois (USA), Abbott is a diversified healthcare group with leadership in cardiovascular devices, diabetes care (FreeStyle Libre), neuromodulation and diagnostics. In Mexico, Abbott employs roughly 1,450 people across offices in Mexico City and Querétaro and inaugurated a new USD 200 million electrophysiology manufacturing plant in Querétaro in January 2026, scaling toward 1,200 specialised jobs by decade-end.

GE Healthcare

GE HealthCare Technologies Inc., spun off from General Electric in January 2023 and headquartered in Chicago, Illinois (USA), is a global leader in diagnostic imaging, ultrasound, patient monitoring and pharmaceutical diagnostics. The company supplies CT, MRI and ultrasound systems to IMSS, ISSSTE and private hospital networks across Mexico, and in November 2025 agreed to acquire imaging-software firm Intelerad for USD 2.3 billion to deepen its cloud-first, AI-enabled imaging stack relevant to Mexican outpatient and ambulatory care.

Other key players in the market are Fresenius Medical Care AG & Co., Koninklijke Philips N.V., Siemens Healthcare GmbH, 3M Company, and Others.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Key Findings From the Mexico Medical Devices Market Report

  • Comprehensive quantitative and qualitative analysis of the market with historical and forecast data from 2026 to 2035
  • Detailed segmentation by product, application, end user and regional trends across Mexico
  • Analysis of the competitive landscape profiling Medtronic, Johnson & Johnson MedTech, Abbott, GE Healthcare, Philips, Siemens Healthineers, Fresenius Medical Care and 3M with their market share, strategies and innovations
  • Assessment of the COFEPRIS regulatory framework, the September 2025 Abbreviated Regulatory Pathway, NOM-241 GMP standards and post-market surveillance impacts
  • Insights on chronic disease burden, IMSS-Bienestar hospital expansion, medical-tourism demand and connected-care adoption
  • Strategic recommendations for manufacturers, distributors and investors based on nearshoring trends, USMCA dynamics and Plan México incentives

Why Choose Expert Market Research?

  • Trusted globally for accurate, evidence-led market intelligence and forecasts that hold up under client and investor scrutiny.
  • Reports validated by experienced sector analysts and on-the-ground Mexican market specialists with direct industry exposure.
  • Actionable findings designed to inform strategic planning, go-to-market design and product development decisions.
  • Flexible, customisable research scope tailored to specific business questions, geographies and investment theses.

Call to Action

Discover the latest insights on the Mexico Medical Devices Market 2026 with our comprehensive report. Stay ahead of the curve with up-to-date data on product innovation, COFEPRIS regulatory shifts, IMSS-Bienestar procurement waves and the highest-growth regional clusters. Whether you are launching a new device, scaling near-shore manufacturing, or expanding distribution, this report gives you the clarity needed to act with confidence. Download your free sample now and uncover the key opportunities reshaping the thriving Mexico Medical Devices.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

At 2025, the market reached an approximate value of USD 8.41 Billion.

The market is projected to grow at a CAGR of 5.30% between 2026 and 2035.

The market is projected to grow significantly during the forecast period 2026-2035 to reach USD 14.10 Billion by 2035.

Growth is anchored by four reinforcing forces: the rising chronic disease burden - particularly cardiovascular disease and diabetes; nearshoring of medical device manufacturing into Tijuana, Ciudad Juárez and Querétaro under USMCA and Plan México; the COFEPRIS Abbreviated Regulatory Pathway launched in September 2025 that compresses approval timelines to as little as 30 business days; and large-scale IMSS-Bienestar and ISSSTE hospital openings and operating-room upgrades equipped with imaging, surgical and cardiology technologies.

By product, the market is segmented into respiratory devices, cardiology devices, orthopedic devices, diagnostic imaging devices, endoscopy devices, ophthalmology devices and others. Diagnostic imaging devices currently lead the segment in Mexico, supported by sustained CT, MRI, ultrasound and X-ray procurement under public hospital modernisation and private medical-tourism investment, with cardiology devices forming the closely followed second-largest cluster.

The four defining trends are: (i) the COFEPRIS Abbreviated Regulatory Pathway, effective September 2025, which recognises FDA, EMA, Health Canada and other IMDRF/MDSAP approvals; (ii) up to USD 400 million in industry investment between 2026 and 2030 announced by AMID under Plan México; (iii) accelerated IMSS-Bienestar hospital and operating-room build-out, with 31 hospitals and 12 clinics targeted for inauguration by end-2025; and (iv) the embedding of AI and connected-device platforms into cardiac imaging, ultrasound and remote patient monitoring portfolios.

The key players in the market include Medtronic plc, Johnson & Johnson MedTech, Fresenius Medical Care AG & Co., Abbott, GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, and 3M Company.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Application
  • End User
  • Region
Breakup by Product
  • Respiratory Devices
  • Cardiology Devices
  • Orthopedic Devices
  • Diagnostic Imaging Devices
  • Endoscopy Devices
  • Ophthalmology Devices
  • Others
Breakup by Application
  • Cardiology
  • Neurology
  • Orthopedics
  • Diabetes Care
  • Respiratory
  • Ophthalmology
  • Oncology
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • Northern Mexico
  • Central Mexico
  • Southern Mexico
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Medtronic plc
  • Johnson & Johnson MedTech
  • Fresenius Medical Care AG & Co.
  • Abbott
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthcare GmbH
  • 3M Company

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us